StockTipsArenaBeta

BUY Mankind Pharma Limited — IDBI Capital

BUYMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

byIDBI CapitalHorizon: 1–3 months19 Jun 2026via IDBI Capital Research Calls Telegram

Entry₹2,425Stated
Target₹2,630
Total upside +8.45% (call closed)
Stop loss₹2,330-3.92% risk
Exit₹2,63015 Jul 2026, 12:07 pm
Target hit+8.45%0.00%upside left
Follow IDBI Capital for new calls(32% target hit, 190 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 2 active Short-term calls on MANKINDSee 39 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 15 Jul 2026
4 supporting4 neutral0 opposing
Supports the BUY call (4)

4 other SEBI-registered advisors have active short-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·9 Jul · 6d ago

2 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·6 Jul · 1w ago

Neutral / worth noting (4)

Mankind Pharma Limited's Board approved the divestment of its 100% stake in Broadway Hospitality Services Private Limited and the incorporation of a wholly-owned subsidiary in Netherlands for R&D inve

NSE · Acquisition·11 Jul · 3d ago

(opens in new tab)

Mankind Pharma Ltd's Board approved the incorporation of a wholly owned subsidiary in the Netherlands.

BSE · Company Update·11 Jul · 3d ago

(opens in new tab)

Mankind Pharma Limited's Board approved the divestment of its 100% stake in Broadway Hospitality Services Private Limited and the incorporation of a wholly owned subsidiary in Netherlands for R&D inve

NSE · Outcome of Board Meeting·11 Jul · 3d ago

(opens in new tab)

Mankind Pharma's Board approved the divestment of its 100% stake in Broadway Hospitality Services Private Limited and the incorporation of a wholly-owned subsidiary in Netherlands for R&D investments.

BSE · Others·11 Jul · 3d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from IDBI Capital

Every call and its outcome